<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T23:44:04Z</responseDate><request verb="GetRecord" identifier="oai:uwspace.uwaterloo.ca:10012/18864" metadataPrefix="dim">https://dspacemainprd01.lib.uwaterloo.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:uwspace.uwaterloo.ca:10012/18864</identifier><datestamp>2025-03-26T23:31:49Z</datestamp><setSpec>com_10012_9936</setSpec><setSpec>com_10012_1</setSpec><setSpec>col_10012_9949</setSpec><setSpec>col_10012_6</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Lu, Qing-Bin</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" authority="fe3c3f01-1305-4415-b429-a5fc253b628b" confidence="600">Xu, Xiangxuan</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2022-10-03T12:35:20Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2023-10-04T04:50:03Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2022-10-03</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2022-09-20</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/10012/18864</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en">Cancer is one of the leading causes threatening human life. People suffering from pancreatic cancer and triple-negative breast cancer (TNBC) have particularly low survival rate among all cancer types. The novel non-platinum based antitumor agents, femtomedicine (FMD) compounds, were discovered as a new class of chemotherapeutic targeting agents to treat multiple cancers. Herein, two of the most effective FMD compounds (FMD-2Br-DAB &amp;amp; FMD-2I-DAB) were evaluated, based on their cytotoxicity against TNBC and pancreatic cancer cells through MTT assay, clonogenic assay, and caspase-3/7 green detection. According to the results obtained from these well-established cell-biology techniques, FMD compounds exhibit good antitumor effects in the cancer cell lines (PANC-1, BXPC-3, and MDA-MB-231), while having minimal impact on the normal cell line (GM05757), indicating FMD compounds can selectively kill TNBC and pancreatic cancer cells without being detrimental to normal cells. Furthermore, FMD-2I-DAB (compound C) shows a better efficiency than FMD-2Br-DAB (compound B), inferring that compound C could be more potent in tumor elimination. This study shows that the FMD compounds, especially for compound C, are potentially new drug candidates for effective treatment of the ‘hard-to-treat’ pancreatic cancer and TNBC.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="dc" element="title" lang="en">Evaluation and Comparison of Two Novel Non-Platinum-Based Antitumor Agents on Pancreatic Cancer and Triple-Negative Breast Cancer</dim:field>
   <dim:field mdschema="dc" element="type" lang="en">Master Thesis</dim:field>
   <dim:field mdschema="dc" element="pending">false</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="department" lang="en">Physics and Astronomy</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="discipline" lang="en">Physics</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="grantor" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="uws-etd" element="degree" lang="en">Master of Science</dim:field>
   <dim:field mdschema="uws-etd" element="embargo" qualifier="terms" lang="en">1 year</dim:field>
   <dim:field mdschema="uws" element="contributor" qualifier="advisor">Lu, Qing-Bin</dim:field>
   <dim:field mdschema="uws" element="contributor" qualifier="affiliation1" lang="en">Faculty of Science</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="city" lang="en">Waterloo</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="country" lang="en">Canada</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="province" lang="en">Ontario</dim:field>
   <dim:field mdschema="uws" element="typeOfResource" lang="en">Text</dim:field>
   <dim:field mdschema="uws" element="peerReviewStatus" lang="en">Unreviewed</dim:field>
   <dim:field mdschema="uws" element="scholarLevel" lang="en">Graduate</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>